Other studies have indicated that METTL3 is downregulated in glioma tissues and regulates U251 cell proliferation and apoptosis by targeting COL4A1 and HSP9, potential therapeutic targets of glioma [54,55]. The gene discussed is METTL3; the disease is glioma.